MFP
EW icon

Meramec Financial Planners’s Edwards Lifesciences EW Stock Holding History

Meramec Financial Planners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831 Hold
10
– – ﹤0.01% 479
2026
Q1 		$815 Hold
10
– – ﹤0.01% 470
2025
Q4 		$788 Buy
+10
New +$821 ﹤0.01% 475

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Meramec Financial Planners's EW Position: Q2 2026 in Review

Meramec Financial Planners held its Edwards Lifesciences (EW) position steady in Q2 2026 at 10 shares worth $831. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Meramec Financial Planners first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Meramec Financial Planners held 10 shares of Edwards Lifesciences worth $831 as of Q2 2026.
  • Meramec Financial Planners left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Meramec Financial Planners's portfolio in Q2 2026, its #479 holding.
  • Meramec Financial Planners first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.